Blood absolute T cell counts may predict 2-month treatment response in patients with pulmonary tuberculosis

Disease Markers

Volumn 28, Issue 6, 2010, Pages 343-352

  Chen, Yung Che ^a,b   Chang, Huang Chih ^a   Chen, Chung Jen ^a   Liu, Shih Feng ^a   Chin, Chien Hung ^a   Wu, Chao Chien ^a   Chao, Tung Ying ^a   Lie, Chien Hao ^a   Wang, Chin Chou ^a   Lin, Meng Chih ^a,c  

^a CHANG GUNG UNIVERSITY COLLEGE OF MEDICINE   (Taiwan)

^b Chang Gurg Technology Institute   (Taiwan)

^c XIAMEN CHANG GUNG HOSPITAL   (China)

Author keywords

Absolute T cell counts; Prediction score; Pulmonary tuberculosis; Slow responders

Indexed keywords

CD3 ANTIGEN; TUBERCULOSTATIC AGENT;

ARTICLE; BLOOD; BLOOD CELL COUNT; CHEMISTRY; FEMALE; HUMAN; LUNG TUBERCULOSIS; LYMPHOCYTE COUNT; MALE; METABOLISM; MIDDLE AGED; PHENOTYPE; PROSPECTIVE STUDY; SPUTUM; SURVIVAL RATE; T LYMPHOCYTE; TREATMENT OUTCOME;

ANTIGENS, CD3; ANTITUBERCULAR AGENTS; BLOOD CELL COUNT; FEMALE; HUMANS; LYMPHOCYTE COUNT; MALE; MIDDLE AGED; PHENOTYPE; PROSPECTIVE STUDIES; SPUTUM; SURVIVAL RATE; T-LYMPHOCYTES; TREATMENT OUTCOME; TUBERCULOSIS, PULMONARY;

EID: 78149490495     PISSN: 02780240     EISSN: 18758630     Source Type: Journal    
DOI: 10.3233/DMA-2010-0714     Document Type: Article

References (31)

1. M. Zierski, E. Bek, M.W. Long and D.E. Snider, Jr., Shortcourse (6-month) cooperative tuberculosis study in Poland: results 30 months after completion of treatment, Am Rev Respir Dis 124 (1981), 249-251.
2. D.A. Mitchison, Assessment of new sterilizing drugs for treating pulmonary tuberculosis by culture at 2 months, Am Rev Respir Dis 147 (1993), 1062-1063.
3. D. Benator, M. Bhattacharya, L. Bozeman, W. Burman, A. Cantazaro, R. Chaisson, F. Gordin, C.R. Horsburgh, J. Horton, A. Khan, C. Lahart, B. Metchock, C. Pachucki, L. Stanton, A. Vernon, M.E. Villarino, Y.C. Wang, M. Weiner and S. Weis, Rifapentine and isoniazid once a week versus rifampicin and isoniazid twice a week for treatment of drug-susceptible pulmonary tuberculosis in HIV-negative patients: a randomised clinical trial, Lancet 360 (2002), 528-534.
4. F.M. Perrin, M.C. Lipman, T.D. McHugh and S.H. Gillespie, Biomarkers of treatment response in clinical trials of novel antituberculosis agents, Lancet Infect Dis 7 (2007), 481-490.
5. G.Walzl, K. Ronacher, J.F. Djoba Siawaya and H.M. Dockrell, Biomarkers for TB treatment response: challenges and future strategies, J Infect 57 (2008), 103-109.
6. C.M. Mason and J. Ali, Immunity against mycobacteria, Semin Respir Crit Care Med 25 (2004), 53-61.
7. M.C. Tsai, S. Chakravarty, G. Zhu, J. Xu, K. Tanaka, C. Koch, J. Tufariello, J. Flynn and J. Chan, Characterization of the tuberculous granuloma in murine and human lungs: cellular composition and relative tissue oxygen tension, Cell Microbiol 8 (2006), 218-232.
8. J. Vani, M.S. Shaila, M.K. Rao, U.M. Krishnaswamy, S.V. Kaveri and J. Bayry, B lymphocytes from patients with tuberculosis exhibit hampered antigen-specific responses with concomitant overexpression of interleukin-8. J Infect Dis 200 (2009), 481-482; author reply 482-484.
9. M. Singhal, J.N. Banavalikar, S. Sharma and K. Saha, Peripheral blood T lymphocyte subpopulations in patients with tuberculosis and the effect of chemotherapy, Tubercle 70 (1989), 171-178.
10. B.E. Jones, M.M. Oo, E.K. Taikwel, D. Qian, A. Kumar, E.R. Maslow and P.F. Barnes, CD4 cell counts in human immunodeficiency virus-negative patients with tuberculosis, Clin Infect Dis 24 (1997), 988-991.
11. W. Barcelos, O.A. Martins-Filho, T.M. Guimaraes, M.H. Oliveira, S. Spindola-de-Miranda, B.N. Carvalho and P. Toledo Vde, Peripheral blood mononuclear cells immunophenotyping in pulmonary tuberculosis patients before and after treatment, Microbiol Immunol 50 (2006), 597-605.
12. F. Deveci, H.H. Akbulut, I. Celik, M.H.Muzand F. Ilhan, Lymphocyte subpopulations in pulmonary tuberculosis patients, Mediators Inflamm 2006 (2006), 1-6.
13. F.M. Al Majid and A.A. Abba, Immunophenotypic characterisation of peripheral T lymphocytes in pulmonary tuberculosis, J Postgrad Med 54 (2008), 7-11.
14. E. Aktas, F. Ciftci, S. Bilgic, O. Sezer, E. Bozkanat, O. Deniz, U. Citici and D. Deniz, Peripheral immune response in pulmonary tuberculosis, Scand J Immunol 70(2009), 300-308.
15. H.M. Blumberg, W.J. Burman, R.E. Chaisson, C.L. Daley, S.C. Etkind, L.N. Friedman, P. Fujiwara, M. Grzemska, P.C. Hopewell, M.D. Iseman, R.M. Jasmer, V. Koppaka, R.I. Menzies, R.J. O’Brien, R.R. Reves, L.B. Reichman, P.M. Simone, J.R. Starke and A.A. Vernon, American Thoracic Society/ Centers for Disease Control and Prevention/Infectious Diseases Society of America: treatment of tuberculosis, Am J Respir Crit Care Med 167 (2003), 603-662.
16. J.D. Christie and D.R. Callihan, The laboratory diagnosis of mycobacterial diseases. Challenges and common sense, Clin Lab Med 15 (1995), 279-306.
17. H.P. McAdams, J. Erasmus and J.A. Winter, Radiologic manifestations of pulmonary tuberculosis, Radiol Clin North Am 33 (1995), 655-678.
18. T. Hertoghe, A. Wajja, L. Ntambi, A. Okwera, M.A. Aziz, C. Hirsch, J. Johnson, Z. Toossi, R. Mugerwa, P. Mugyenyi, R. Colebunders, J. Ellner and G. Vanham, T cell activation, apoptosis and cytokine dysregulation in the (co)pathogenesis of HIV and pulmonary tuberculosis (TB), Clin Exp Immunol 122 (2000), 350-357.
19. C.A. Scanga, V.P. Mohan, K.Yu, H. Joseph, K.Tanaka, J. Chan and J.L. Flynn, Depletion of CD4(+)Tcells causes reactivation of murine persistent tuberculosis despite continued expression of interferon gamma and nitric oxide synthase 2, J Exp Med 192 (2000), 347-358.
20. D.A. Lewinsohn, A.S. Heinzel, J.M. Gardner, L. Zhu, M.R. Alderson and D.M. Lewinsohn, Mycobacterium tuberculosisspecific CD8+ Tcells preferentially recognize heavily infected cells, Am J Respir Crit Care Med 168 (2003), 1346-1352.
21. M. Gonzalez-Juarrero, O.C. Turner, J. Turner, P. Marietta, J.V. Brooks and I.M. Orme, Temporal and spatial arrangement of lymphocytes within lung granulomas induced by aerosol infection with Mycobacterium tuberculosis, Infect Immun 69 (2001), 1722-1728.
22. T.C. Tsao, C.H. Chen, J.H. Hong, M.J. Hsieh, K.C. Tsao and C.H. Lee, Shifts of T4/T8 T lymphocytes from BAL fluid and peripheral blood by clinical grade in patients with pulmonary tuberculosis, Chest 122 (2002), 1285-1291.
23. H. Veenstra, R. Baumann, N.M. Carroll, P.T. Lukey, M. Kidd, N. Beyers, C.T. Bolliger, P.D. van Helden and G. Walzl, Changes in leucocyte and lymphocyte subsets during tuberculosis treatment; prominence of CD3dimCD56+ natural killer T cells in fast treatment responders, Clin Exp Immunol 145 (2006), 252-260.
24. D.L. Cohn, B.J. Catlin, K.L. Peterson, F.N. Judson and J.A. Sbarbaro, A 62-dose, 6-month therapy for pulmonary and extrapulmonary tuberculosis. Atwice-weekly, directly observed, and cost-effective regimen, Ann Intern Med 112 (1990), 407-415.
25. E.Y. Heo, E.J. Chun, C.H. Lee, Y.W. Kim, S.K. Han, Y.S. Shim, H.J. Lee and J.J. Yim, Radiographic improvement and its predictors in patients with pulmonary tuberculosis, Int J Infect Dis 13 (2009), 371-376.
26. R. Singla, D. Srinath, S. Gupta, P. Visalakshi, U.K. Khalid, N. Singla, U.A. Gupta, S.K. Bharty and D. Behera, Risk factors for new pulmonary tuberculosis patients failing treatment under the Revised National Tuberculosis Control Programme, India, Int J Tuberc Lung Dis 13 (2009), 521-526.
27. J.F. Djoba Siawaya, N.B. Bapela, K. Ronacher, H. Veenstra, M. Kidd, R. Gie, N. Beyers, P. van Helden and G. Walzl, Immune parameters as markers of tuberculosis extent of disease and early prediction of anti-tuberculosis chemotherapy response, J Infect 56 (2008), 340-347.
28. R.L. Hunter, M.R. Olsen, C. Jaqannath and J.K. Actor, Multiple roles of cord factor in the pathogenesis of primary, secondary and cavitary tuberculosis, including a revised description of the pathology of secondary disease, Ann Clin Lab Sci 36 (2006), 371-386.
29. B.M. Saunders and W.J. Britton, Life and death in the granuloma: immunopathology of tuberculosis, Immunol Cell Biol 85 (2007), 103-111.
30. J.M. Wallace, N.I. Hansen, L. Lavange, J. Glassroth, B.L. Browdy, M.J. Rosen, P.A. Kvale, B.T. Mangura, L.B. Reichman and P.C. Hopewell, Respiratory disease trends in the Pulmonary Complications of HIV Infection Study cohort. Pulmonary Complications of HIV Infection Study Group, Am J Respir Crit Care Med 155 (1997), 72-80.
31. M. Muyoyeta, J.A. Schaap, P. De Haas, W. Mwanza, M.W. Muvwimi, P. Godfrey-Faussett and H. Ayles, Comparison of four culture systems for Mycobacterium tuberculosis in the Zambian National Reference Laboratory, Int J Tuberc Lung Dis 13 (2009), 460-465.